Related Experiment Video
Updated: Dec 9, 2025

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
lncRNA SNHG1 attenuates osteogenic differentiation via the miR‑101/DKK1 axis in bone marrow mesenchymal stem cells
Jie Xiang1, Hai-Qing Fu2, Zhun Xu2
1Department of Orthopedics and Traumatology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China.
Abstract:
The imbalance induced by inhibition of bone mesenchymal stem cell (BMSC) osteogenic differentiation results in osteoporosis (OP); however, the underlying regulatory mechanism is not completely understood. Long non‑coding RNAs (lncRNAs) serve crucial roles in osteogenic differentiation; therefore, investigating their regulatory role in the process of osteogenic differentiation may identify a promising therapeutic target for OP. The expression of small nucleolar RNA host gene 1 (SNHG1), Dickkopf 1 (DKK1), microRNA (miR)‑101, RUNX family transcription factor 2 (RUNX2), osteopontin (OPN) and osteocalin (OCN) were detected via reverse transcription‑quantitative PCR. The protein expression levels of DKK1, β‑catenin, RUNX2, OPN, OCN, osterix and collagen type I α1 chain were analyzed by performing western blotting. The osteoblastic phenotype was assessed by conducting alkaline phosphatase activity detection and Alizarin Red staining. The interaction between SNHG1 and miR‑101 was validated by bioinformatics and luciferase assays. The regulatory role of SNHG1 in BMSC osteogenic differentiation was assessed. SNHG1 expression was downregulated in a time‑dependent manner during the process of osteogenic differentiation. SNHG1 overexpression inhibited osteogenic differentiation compared with the pcDNA group. The results indicated that SNHG1 and DKK1 directly interacted with miR‑101. Moreover, SNHG1 regulated the Wnt/β‑catenin signaling pathway to inhibit osteogenic differentiation via the miR‑101/DKK1 axis. The present study indicated that lncRNA SNHG1 could attenuate BMSC osteogenic differentiation via the miR‑101/DKK1 axis as a competitive endogenous RNA. Therefore, the present study furthered the current understanding of the potential mechanism underlying lncRNAs in in osteogenic differentiation.
Insights
Long non-coding RNA SNHG1 inhibits bone mesenchymal stem cell differentiation, potentially offering a new therapeutic target for osteoporosis. This study uncovers the miR-101/DKK1 pathway
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Osteoporosis (OP) is linked to impaired bone mesenchymal stem cell (BMSC) osteogenic differentiation.
- The precise regulatory mechanisms governing this process, particularly involving long non-coding RNAs (lncRNAs), remain incompletely understood.
- Identifying novel therapeutic targets for OP is crucial.
Purpose of the Study:
- To investigate the regulatory role of lncRNA small nucleolar RNA host gene 1 (SNHG1) in BMSC osteogenic differentiation.
- To elucidate the molecular mechanism by which SNHG1 influences osteogenesis, focusing on its interaction with microRNA (miR)-101 and Dickkopf-1 (DKK1).
- To explore the potential of targeting the SNHG1/miR-101/DKK1 axis for OP treatment.
Main Methods:
- Quantitative reverse transcription PCR (RT-qPCR) to measure gene expression (SNHG1, DKK1, miR-101, RUNX2, OPN, OCN).
- Western blotting to analyze protein expression levels (DKK1, β-catenin, RUNX2, OPN, OCN, osterix, collagen type I α1).
- Functional assays including alkaline phosphatase activity, Alizarin Red staining, bioinformatics analysis, and luciferase assays to validate interactions and assess osteoblastic phenotype.
Main Results:
- SNHG1 expression decreased in a time-dependent manner during osteogenic differentiation.
- Overexpression of SNHG1 significantly inhibited BMSC osteogenic differentiation.
- SNHG1 was found to directly interact with miR-101 and regulate the Wnt/β-catenin signaling pathway via the miR-101/DKK1 axis, thereby inhibiting osteogenic differentiation.
Conclusions:
- lncRNA SNHG1 acts as a competitive endogenous RNA (ceRNA) to attenuate BMSC osteogenic differentiation.
- The inhibitory effect of SNHG1 on osteogenesis is mediated through the miR-101/DKK1 axis.
- This study enhances the understanding of lncRNA-mediated regulation in osteogenic differentiation and suggests SNHG1 as a potential therapeutic target for osteoporosis.
More Related Videos
07:05TGF-β-mediated Endothelial to Mesenchymal Transition EndMT and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing
Published on: February 26, 2021
10:48Differentiation of a Human Neural Stem Cell Line on Three Dimensional Cultures, Analysis of MicroRNA and Putative Target Genes
Published on: April 12, 2015
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Mesenchymal Stem Cells
Stem Cell Niche